AlphaYouJC
Congress trade
Rep. John Curtis (R-UT) sold $1K-$15K of Abbott Laboratories (ABT) stock
John Curtis, U.S. Representative (R-UT), disclosed a sale of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Nov 9, 2022.
The trade happened on Oct 21, 2022, 19 days before it was made public.
ABT has moved +2.6% since the trade date, from $95.06 to $97.50 (Oct 2, 2026 close).
- Traded
- Oct 21, 2022
- Disclosed
- Nov 9, 2022
- Filing delay
- 19 days
- Price since
- +2.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (4)
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.